References
- Shriver D A, Rosenthale M E, Kluender H C, Schut R N, McGuire J L, Hong E. Pharmacology of rio-prostil, a new gastric cytoprotective/antisecretory agent. Arzneim Forsch/Drug Res 1985; 35(1)839–843
- Winterhager J M. Effects of rioprostil, PGE1, and dimethyl-PGE2 on HCO3 secretion by guinea-pig fundic mucosa in vitro. Naunyn Schmiederbergs Arch Pharmacol 1986; 332(Suppl)247, (Abstract)
- Scott C K, Castrovilly L, Shriver D A, Tolman E L, McGuire J L, Rosenthale M E, Morris G P, Keenan C M. 6th Int Conf on Prostaglandins and Related Compounds. June 3–6, 1986, A328, Florence
- Scott C K, Tolman E L, Rosenthale M E. 1985; A9471, Ortho-internal pharma report
- Demol P, Wingender W, Weihrauch T R, Graefe K H. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1. Arzneim Forsch/Drug Res 1985; 35(1)861–863
- Schulte K, Singer M V, Eysselein V, Demol P, Goebell H. Effect of rioprostil, a synthetic prostaglandin E1 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans. 1987; 36: 162–167
- Fordtran J S, Walsh J H. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest 1973; 52: 645–657
- Dammann H G, Rehner M, Walter T A, Muller P, Simon B. Rioprostil 600 micrograms nocte: Aus-gepragte Hemmung der nachtlichen intragastralie Aziditat des Menschen. Z Gastroenterol 1986; 24: 245–249
- Dammann H G, Walter T A, Muller P, Simon B. Rioprostil 600 μg nocte: high duodenal ulcer healing rates, low incidence of side effects. Gastroenterology 1986; 90: 1386, 5(2)
- Hunt R H, Howden C W, Jones D B, Burget D W, Kerr G D. The correlation between acid suppression and peptic ulcer healing. Scand J Gastroenterol 1986; 21(Suppl 125)22–29
- McGuigan J E, Chang Y, Dajani E Z. Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer. Dig Dis Sci 1986; 31(Suppl)120S–125S